Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2005
06/23/2005WO2005056015A1 Substituted piperazines
06/23/2005WO2005056013A1 Dpp-iv inhibitors
06/23/2005WO2005056004A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
06/23/2005WO2005056003A1 Dpp-iv inhibitors
06/23/2005WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
06/23/2005WO2005042444A3 Platinum complex and luminescent element
06/23/2005WO2005040129A3 Ccr3 receptor antagonists
06/23/2005WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
06/23/2005WO2005034870A3 Amide compounds and ion channel ligands and uses thereof
06/23/2005WO2005033105A3 Vanilloid receptor ligands and their use in treatments
06/23/2005WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
06/23/2005WO2005016885A3 COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE
06/23/2005WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
06/23/2005WO2004089307A8 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
06/23/2005WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
06/23/2005US20050137405 Reacting o-chlorobenzaldehyde with an alkyl 4-(phthalimido)ethoxy)acetoacetate to yield alkyl 2-(o-chlorobenzylidene)-4-(2-phthalimidoethoxy)acetoacetate which upon reacting with an alkyl -3-aminocrotonate yields a phtahalimiamlodipine; good yields and purity; useful as reference standards or markers
06/23/2005US20050137399 A lithium-free reaction to produce a substituted/unsubstituted 4-amino-3-benzimidazol-2-yl-quinolin-2-one compound by reacting a 2-aminobenzonitrile with a 2-alkyloxycarbonylmethyl-benzimidazole in a solvent in the presence of a sodium or potassium salt of a base; excellent yields
06/23/2005US20050137395 E.g., 6-[(7-iodoquinolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide; antiproliferative agent for hyperproliferative disorders being either cancerous or noncancerous; vasculogenesis or angiogenesis inhibitors; adminstered with hypotensive agent, antitumor agents, mitotic inhibitors and others
06/23/2005US20050137243 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137234 Histone deacetylase inhibitors
06/23/2005US20050137233 Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137228 Benzyl sulfonamide derivatives
06/23/2005US20050137224 2-Cyanopyrrolidinecarboxamide compound
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
06/23/2005US20050137212 Hppars activators
06/23/2005US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment
06/23/2005US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors
06/23/2005US20050137200 Potassium channel modulators; antiarrhythmia agents
06/23/2005US20050137196 Medical devices employing triazine compounds and compositions thereof
06/23/2005US20050137193 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/23/2005US20050137187 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke
06/23/2005US20050137139 Peptidomimetic compounds, useful as antiviral agents; used to inhibit HCV replication and to lessen the risk of or the severity of HCV infection
06/23/2005US20050136620 Maleimide compounds in liquid form
06/23/2005US20050135737 Optical interleaver
06/23/2005DE10353657A1 New quinolonyl- or benzopyranonyl-substituted indole derivatives are 5HT(1A)- and/or 5HT(1D)-agonists useful e.g. as anxiolytic, antidepressant, neuroleptic and/or antihypertensive agents
06/23/2005CA2549548A1 Carboxamide derivatives
06/23/2005CA2549401A1 Heterocyclic anti-migraine agents
06/23/2005CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2548742A1 Dpp-iv inhibitors
06/23/2005CA2548426A1 Substituted piperazines
06/23/2005CA2548276A1 Keto lactam compounds and use thereof
06/23/2005CA2548262A1 Method for the production of tetrahydrogeranylacetone
06/23/2005CA2548172A1 Quinoxalines useful as inhibitors of protein kinases
06/23/2005CA2547863A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
06/23/2005CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
06/23/2005CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production
06/23/2005CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/22/2005EP1544197A1 Intermediates for cephem compounds
06/22/2005EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
06/22/2005EP1542993A1 Piperazine derivatives and methods of use
06/22/2005EP1542991A1 Pyrimidine compounds as therapeutic agents
06/22/2005EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542989A1 Protein tyrosine kinase inhibitors
06/22/2005EP1542988A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same
06/22/2005EP1542987A1 Piperidine-n-oxide-derivatives
06/22/2005EP1542986A1 An improved process for the production of desloratadine
06/22/2005EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
06/22/2005EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
06/22/2005EP1542973A1 2,4-substituted indoles and their use as 5-ht6 modulators
06/22/2005EP1542971A1 4-pyrrolidino-phenyl-benzyl ether derivatives
06/22/2005EP1542970A1 Pyrrolidone derivatives as maob inhibitors
06/22/2005EP1542969A1 Pyrrolidone derivatives as maob inhibitors
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1542689A2 Improved process for hydroxyazapirones
06/22/2005EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors
06/22/2005EP1542684A2 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542680A1 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives s tnf-alpha and interleukin lowering agents for the treatment of inflammations
06/22/2005EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/22/2005EP1455787B1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders
06/22/2005EP1436282B1 Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
06/22/2005EP1268466B1 Decahydro-isoquinolines
06/22/2005EP1191025B1 Crystals of lansoprazole
06/22/2005EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005EP1040111B1 Integrin receptor antagonists
06/22/2005CN1630658A Variolin derivatives as anti-cancer agents
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1630652A New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
06/22/2005CN1630651A Novel gamma secretase inhibitors
06/22/2005CN1630650A Nitrogenous heterocyclic compound and medicine thereof
06/22/2005CN1630648A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630644A Pyridine and pyrimidine derivatives
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630641A Farnesyl protein transferase inhibitors as antitumor agents
06/22/2005CN1630640A Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1629155A Pyrimidinyl carboxylic acid amide compounds with anti-tumor activity and salts thereof
06/22/2005CN1629142A Piperazine-bridged tacrine binary derivatives and synthesis method thereof
06/22/2005CN1207295C Method for preparing pyrazo-(4, 3-d) pyrimidine-7-ketone and its intermediate
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207288C Retroviral protease inhibiting compounds
1 ... 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 ... 1080